Intellia Therapeutics Inc (NTLA) earnings · rev $67.7M
These earnings events as JSON? API free 100/dayIntellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
This NTLA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NTLA revenue for 2025-12-31 was $67.7M. Net income was -$412.7M. Revenue was up 16.9% from 2024-12-31 to 2025-12-31. NTLA currently screens at market cap $1.19B.
When the next NTLA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 16.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full NTLA research stays on the stock page; the tape stays on the quote page.
NTLA earnings FAQ
What are NTLA's latest revenue and net income?
Latest cached Intellia Therapeutics Inc (NTLA) revenue for Dec 31, 2025 was $67.7M. Net income was -$412.7M. Statements: https://lician.com/financials/ntla
What is NTLA's latest diluted EPS?
Latest cached Intellia Therapeutics Inc (NTLA) diluted EPS for Dec 31, 2025 was -$3.81.
What period does the latest NTLA earnings print cover?
The latest cached Intellia Therapeutics Inc (NTLA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did NTLA revenue change from the prior cached period?
Cached Intellia Therapeutics Inc (NTLA) revenue was up 16.9% from $57.9M (Dec 31, 2024) to $67.7M (Dec 31, 2025). Statements: https://lician.com/financials/ntla
Where are NTLA earnings listed?
Cached earnings facts for Intellia Therapeutics Inc (NTLA) are listed at https://lician.com/earnings/ntla. Statements: https://lician.com/financials/ntla
Not investment advice.